232 related articles for article (PubMed ID: 28991298)
1. Exosomal delivery of berry anthocyanidins for the management of ovarian cancer.
Aqil F; Jeyabalan J; Agrawal AK; Kyakulaga AH; Munagala R; Parker L; Gupta RC
Food Funct; 2017 Nov; 8(11):4100-4107. PubMed ID: 28991298
[TBL] [Abstract][Full Text] [Related]
2. Exosomal formulation of anthocyanidins against multiple cancer types.
Munagala R; Aqil F; Jeyabalan J; Agrawal AK; Mudd AM; Kyakulaga AH; Singh IP; Vadhanam MV; Gupta RC
Cancer Lett; 2017 May; 393():94-102. PubMed ID: 28202351
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of Colorectal Cancer by Anthocyanidins and Mitigation of Metabolic Shifts Induced by Dysbiosis of the Gut Microbiome.
Mudd AM; Gu T; Munagala R; Jeyabalan J; Egilmez NK; Gupta RC
Cancer Prev Res (Phila); 2020 Jan; 13(1):41-52. PubMed ID: 31796466
[TBL] [Abstract][Full Text] [Related]
4. Milk-derived exosomes for oral delivery of paclitaxel.
Agrawal AK; Aqil F; Jeyabalan J; Spencer WA; Beck J; Gachuki BW; Alhakeem SS; Oben K; Munagala R; Bondada S; Gupta RC
Nanomedicine; 2017 Jul; 13(5):1627-1636. PubMed ID: 28300659
[TBL] [Abstract][Full Text] [Related]
5. Targeted Oral Delivery of Paclitaxel Using Colostrum-Derived Exosomes.
Kandimalla R; Aqil F; Alhakeem SS; Jeyabalan J; Tyagi N; Agrawal A; Yan J; Spencer W; Bondada S; Gupta RC
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359601
[TBL] [Abstract][Full Text] [Related]
6. Anthocyanidins Inhibit Growth and Chemosensitize Triple-Negative Breast Cancer via the NF-κB Signaling Pathway.
Aqil F; Munagala R; Agrawal AK; Jeyabalan J; Tyagi N; Rai SN; Gupta RC
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944868
[TBL] [Abstract][Full Text] [Related]
7. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
Ma JJ; Chen BL; Xin XY
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
Henkels KM; Turchi JJ
Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
[TBL] [Abstract][Full Text] [Related]
9. The anti-tumor effect of cross-reacting material 197, an inhibitor of heparin-binding EGF-like growth factor, in human resistant ovarian cancer.
Tang XH; Deng S; Li M; Lu MS
Biochem Biophys Res Commun; 2012 Jun; 422(4):676-80. PubMed ID: 22609777
[TBL] [Abstract][Full Text] [Related]
10. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
[TBL] [Abstract][Full Text] [Related]
11. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
[TBL] [Abstract][Full Text] [Related]
12. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
Tong L; Chen W; Wu J; Li H
Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314
[TBL] [Abstract][Full Text] [Related]
13. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
[TBL] [Abstract][Full Text] [Related]
14. The effects of umbilical cord-derived macrophage exosomes loaded with cisplatin on the growth and drug resistance of ovarian cancer cells.
Zhang X; Liu L; Tang M; Li H; Guo X; Yang X
Drug Dev Ind Pharm; 2020 Jul; 46(7):1150-1162. PubMed ID: 32482115
[No Abstract] [Full Text] [Related]
15. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
Yang YI; Kim JH; Lee KT; Choi JH
Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy.
He J; Yu JJ; Xu Q; Wang L; Zheng JZ; Liu LZ; Jiang BH
Autophagy; 2015; 11(2):373-84. PubMed ID: 25650716
[TBL] [Abstract][Full Text] [Related]
17. Sequential combination therapy of ovarian cancer with cisplatin and γ-secretase inhibitor MK-0752.
Chen X; Gong L; Ou R; Zheng Z; Chen J; Xie F; Huang X; Qiu J; Zhang W; Jiang Q; Yang Y; Zhu H; Shi Z; Yan X
Gynecol Oncol; 2016 Mar; 140(3):537-44. PubMed ID: 26704638
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B X-interacting protein promotes cisplatin resistance and regulates CD147 via Sp1 in ovarian cancer.
Zou W; Ma X; Yang H; Hua W; Chen B; Cai G
Exp Biol Med (Maywood); 2017 Mar; 242(5):497-504. PubMed ID: 28056551
[TBL] [Abstract][Full Text] [Related]
19. Tumoricidal activity of combining the agonistic DR5 antibody D-6 with cisplatin in C30 cisplatin-resistant ovarian cancer in vitro and in vivo.
Huang Y; Liang B; Jiang Q; Chen C; Yang K; Li C; Zheng A
Mol Med Rep; 2014 Jul; 10(1):183-90. PubMed ID: 24789319
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
